Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline.
作者信息
Ott E, Lechner H
出版信息
Ric Clin Lab. 1981;11 Suppl 1:253-6.
PMID:7188113
Abstract
In 55 patients with acute or subacute CVD a beneficial but dose dependent effect of PO on human blood rheologic properties has been demonstrated, indicated by a lowering of blood viscosity, a decrease of fibrinogen concentration and inhibition of PA.
摘要
相似文献
1
Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline.
Ric Clin Lab. 1981;11 Suppl 1:253-6.
2
[Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
Ric Clin Lab. 1981;11 Suppl 1:303-11.
3
Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency.
Eur Neurol. 1983;22 Suppl 1:105-7. doi: 10.1159/000115658.
4
5
Special therapeutical aspects of cerebrovascular disease.
Ric Clin Lab. 1981;11 Suppl 1:247-51.
6
Hemorheology and peripheral vascular diseases: a new therapeutic approach.
J Med. 1981;12(4):209-35.
7
[Combination of phosphatidylcholine and pentoxifylline in the therapy of progressive obstructive stroke].
Acta Neurol Quad (Napoli). 1979;39:226-8.
8
The influence of I.V. application of pentoxifylline on the viscoelasticity of blood in patients with peripheral vascular disorders.
Ric Clin Lab. 1981;11 Suppl 1:189-96.
9
Update on the pharmacology of pentoxifylline and its combination with low-dose acetylsalicylic acid (HWA 5112).
Semin Thromb Hemost. 1989 Apr;15(2):150-8. doi: 10.1055/s-2007-1002698.
10
[Rheologic effect of naftidrofuryl and pentoxifylline].
Med Welt. 1983 Jul 29;34(29-30):833-6.
Zotero 插件